Remedent Inc.: Company Announcement

Remedent Inc.: Company Announcement 


DEURLE, Belgium, June 10  /PRNewswire-FirstCall/ -- Remedent Inc. (REMI)
announced today that it has completed the following effective as of close of
business June 3, 2005:

   1. The implementation of a one for twenty reverse stock split;

   2. The change of our name from "Remedent USA, Inc." to
      "Remedent, Inc" (REMI-OTC Bulletin Board);

   3. The acquisition of the remaining 78% of our subsidiary,
      Remedent N.V., through the issuance of shares of our common stock
      equal to 78% of our issued and outstanding shares following the
      completion of the transaction.



These corporate actions were taken in accordance with a shareholder's written
consent as described more fully in an information statement filed with the
Securities and Exchange Commission by Remedent on May 9, 2005 and which became
effective June 3, 2005.

"These events represent key steps in Remedent's goals of continuing to expand
its leadership role as innovators in the tooth whitening industry in Europe and
Asia as well as begin to establish operations in the United States," stated Guy
DeVreese, the Company's Chairman of the Board.

About Remedent Inc.

Remedent Inc., and its subsidiary Remedent NV based in Deurle, Belgium
("Remedent"), is a leading provider of cosmetic dentistry products, including a
full line of professional dental and retail "over the counter" tooth whitening
products with distribution that, to date, encompasses over 35 countries
throughout Europe, Asia and South America.

This press release contains forward-looking statements made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking statements.
When used in this release, the words "anticipate," "believe," "estimate,"
"expect" and similar expressions are intended to identify such forward-looking
statements. Remedent, Inc.'s actual results, performance or achievements could
differ materially from the results expressed in, or implied by these
forward-looking statements. For more detailed information relating to the risks
and uncertainties pertaining to these forward-looking statements, the reader is
referred to the "risk factors" section in Remedent Inc.'s Form 10-KSB and other
related documents filed with the Securities and Exchange Commission. 

DATASOURCE: Remedent Inc.



CONTACT:  Guy De Vreese, Chairman of Remedent Inc., [phone] 

Copyright